Matthew Gantz

Executive Vice President
Medicine
Swedish Orphan Biovitrum AB (publ)
Sweden

Business Expert Reproductive Medicine
Biography

Born 1965. BA Princeton University and MBA from Harvard Business School. Board member since 2012. Other appointments: Executive Vice President of BTG, an international specialist healthcare company. Previous appointments: Founder and previously CEO of Acureon Pharmaceuticals, President and CEO of Hydrabiosciences Inc., VP Europe for Chiron's Biopharmaceutical Division and General Manager for PathoGenesis Europe. Prior to Chiron/PathoGenesis a variety of US sales and marketing roles at Abbott Laboratories Diagnostic Division.

Research Intrest

 He is interested in Medicine.